Safety and Efficacy of VB-111 in Subjects With Advanced Differentiated Thyroid Cancer
Clinical trial NCT01229865 · COMPLETED
Trial details
- NCT number
- NCT01229865
- Sponsor
- Vascular Biogenics Ltd. operating as VBL Therapeutics
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-12-01
- Primary completion
- 2014-10-01
- Enrollment
- 29
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.